Medical Economics January 4, 2024
Richard Payerchin

Report to Congress details expected recoveries, questioned costs, and potential savings.

Audits and investigations of participants in federal health programs continued in the second half of fiscal year 2023, according to a new report from the U.S. Department of Health and Human Services’ Office of Inspector General (HHS-OIG).

Spring, summer and fall 2023 generated 65 audit reports and 22 evaluation reports identifying $82.7 million in expected recoveries and $1.2 billion in questioned costs, according to HHS-OIG.

Along with allegations of waste, fraud and abuse, HHS could save up to $47.2 million if the federal department implemented all of the OIG’s audit recommendations, said the “Semiannual Report to Congress” by Inspector General Christi A. Grimm. The report covered the six-month period...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, OIG, Provider, Survey / Study, Trends
HHS-OIG Highlights Anti-Fraud Safeguards of Drug Manufacturer’s Free Drug Program for Patients in Financial Need
Putting infection control to the test
HHS OIG Finds Favorably for Free Access to Pharmaceutical Product
FDA’s Recent Guidance on Accelerated Approval and Implications for Rare Diseases
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023

Share This Article